{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T03:07:24Z","timestamp":1785812844274,"version":"3.56.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2011,9,23]],"date-time":"2011-09-23T00:00:00Z","timestamp":1316736000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s00066-011-1111-7","type":"journal-article","created":{"date-parts":[[2011,9,22]],"date-time":"2011-09-22T05:30:31Z","timestamp":1316669431000},"page":"645-650","source":"Crossref","is-referenced-by-count":15,"title":["Definitive radiochemotherapy of advanced head and neck cancer with carboplatin and paclitaxel","Definitive Radiochemotherapie fortgeschrittener Kopf-Hals-Tumoren mit Carboplatin und Paclitaxel"],"prefix":"10.1007","volume":"187","author":[{"given":"Robert","family":"Semrau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Temming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon Florian","family":"Preuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Peter","family":"Klu\u00dfmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlando","family":"Guntinas-Lichius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf-Peter","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,23]]},"reference":[{"key":"1111_CR1","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0360-3016(02)02816-X","volume":"53","author":"A. Abitbol","year":"2002","unstructured":"Abitbol A, Abdel-Wahab M, Lewin A et al. Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and\/or unresectable head- and-neck squamous cell carcinoma: A-2 protocol. Int J Radiat Oncol Biol Phys 2002;53:942\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1111_CR2","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/annonc\/mdm088","volume":"18","author":"S.S. Agarwala","year":"2007","unstructured":"Agarwala SS, Cano E, Heron DE et al. Long-term outcomes with concurrent carboplatin, paclitaxel and radiation therapy for locally advanced, inoperable head and neck cancer. Ann Oncol 2007;18:1224\u20139.","journal-title":"Ann Oncol"},{"key":"1111_CR3","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00066-009-2092-7","volume":"185","author":"P. Balermpas","year":"2009","unstructured":"Balermpas P, Hambek M, Seitz O et al. Combined cetuximab and reirradiation for locoregional recurrent and inoperable squamous cell carcinoma of the head and neck. Strahlenther Onkol 2009;185:775\u201381.","journal-title":"Strahlenther Onkol"},{"key":"1111_CR4","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1200\/JCO.2005.07.010","volume":"23","author":"V. Budach","year":"2005","unstructured":"Budach V, Stuschke M, Budach W et al. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial. J Clin Oncol 2005;23:1125\u201335.","journal-title":"J Clin Oncol"},{"key":"1111_CR5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.clon.2010.07.015","volume":"23","author":"A.K. Chan","year":"2011","unstructured":"Chan AK, Sanghera P, Choo BA et al. Hypofractionated accelerated radiotherapy with concurrent carboplatin for locally advanced squamous cell carcinoma of the head and neck. Clinical Oncology 2011;23:34\u20139.","journal-title":"Clinical Oncology"},{"key":"1111_CR6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hed.20700","volume":"30","author":"P.B. Chougule","year":"2008","unstructured":"Chougule PB, Akhtar MS, Rathore R et al. Concurrent chemoradiotherapy with weekly paclitaxel and carboplatin for locally advanced head and neck cancer: long-term follow-up of a Brown University Oncology Group Phase II Study (HN-53). Head Neck 2008;30:289\u201396.","journal-title":"Head Neck"},{"issue":"4","key":"1111_CR7","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.ijrobp.2008.09.053","volume":"74","author":"D. Citrin","year":"2009","unstructured":"Citrin D, Mansueti J, Likhacheva A et al. Long-term outcomes and toxicity of concurrent paclitaxel and radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2009;74(4):1040\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1111_CR8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/hed.20522","volume":"29","author":"A.J. Cmelak","year":"2007","unstructured":"Cmelak AJ, Murphy BA, Burkey B et al. Taxane-based chemoirradiation for organ preservation with locally advanced head and neck cancer: results of a phase II multi-institutional trial. Head Neck 2007;29:315\u201324.","journal-title":"Head Neck"},{"key":"1111_CR9","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.ijrobp.2009.04.011","volume":"76","author":"A. Eisbruch","year":"2010","unstructured":"Eisbruch A, Harris J, Garden AS et al. Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22). Int Journal Radiat Oncol Biol Phys 2010;76:1333\u20138.","journal-title":"Int Journal Radiat Oncol Biol Phys"},{"key":"1111_CR10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00066-004-1307-1","volume":"180","author":"A. Ernst-Stecken","year":"2004","unstructured":"Ernst-Stecken A, Grabenbauer G, Iro H et al. Phase II trial of hyperfractionated accelerated split-course radiochemotherapy with 5-FU and cis-DDP in advanced head and neck cancer. Strahlenther Onkol 2004;180:805\u201310.","journal-title":"Strahlenther Onkol"},{"key":"1111_CR11","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/hed.10049","volume":"24","author":"O. Feher","year":"2002","unstructured":"Feher O, Martins SJ, Lima CA et al. Pilot trial of concomitant chemotherapy with paclitaxel and split-course radiotherapy for very advanced squamous cell carcinoma of head and neck. Head Neck 2002;24:228\u201335.","journal-title":"Head Neck"},{"key":"1111_CR12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.radonc.2006.03.009","volume":"79","author":"V. Gregoire","year":"2006","unstructured":"Gregoire V, Eisbruch A, Hamoir M et al. Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck. Radiother Oncol 2006;79:15\u201320.","journal-title":"Radiother Oncol"},{"key":"1111_CR13","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1002\/cncr.24525","volume":"115","author":"R. Haddad","year":"2009","unstructured":"Haddad R, Sonis S, Posner M et al. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin\/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer. Cancer 2009;115:4514\u201323.","journal-title":"Cancer"},{"key":"1111_CR14","doi-asserted-by":"crossref","unstructured":"Halim AA, Wahba HA, El-Hadaad HA et al. Concomitant chemoradiotherapy using low-dose weekly gemcitabine versus low-dose weekly paclitaxel in locally advanced head and neck squamous cell carcinoma: a phase III study. Med Oncol 2011. DOI: 10.1007\/s12032-010-9811-x.","DOI":"10.1007\/s12032-010-9811-x"},{"key":"1111_CR15","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00066-003-1106-0","volume":"179","author":"T. Kuhnt","year":"2003","unstructured":"Kuhnt T, Becker A, Pigorsch S et al. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial. Strahlenther Onkol 2003;179:673\u201381.","journal-title":"Strahlenther Onkol"},{"key":"1111_CR16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0360-3016(99)00027-9","volume":"44","author":"M. Machtay","year":"1999","unstructured":"Machtay M, Aviles V, Kligerman MM et al. A phase I trial of 96-hour paclitaxel infusion plus accelerated radiotherapy of unrespectable head and neck cancer. Int J Radiat Oncol Biol Phys 1999;44:311\u20135.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1111_CR17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","volume":"92","author":"J.P. Pignon","year":"2009","unstructured":"Pignon JP, le Maitre A, Maillard E et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009;92:4\u201314.","journal-title":"Radiother Oncol"},{"key":"1111_CR18","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.oraloncology.2006.04.015","volume":"43","author":"S.F. Preuss","year":"2007","unstructured":"Preuss SF, Dinh V, Klussmann JP et al. Outcome of multimodal treatment for oropharyngeal carcinoma: a single institution experience. Oral Oncology 2007;43:402\u20137.","journal-title":"Oral Oncology"},{"key":"1111_CR19","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ijrobp.2007.01.010","volume":"8","author":"G. Sanguinetti","year":"2007","unstructured":"Sanguinetti G, Adapala P, Endres EJ et al. Dosimetric predictors of laryngeal edema. Int J Radiat Oncology Biol Phys 2007; 8:741\u20139.","journal-title":"Int J Radiat Oncology Biol Phys"},{"key":"1111_CR20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00066-011-2217-7","volume":"187","author":"E. Selzer","year":"2011","unstructured":"Selzer E, Liederer S, Lemaire C et al. Incidence of dermatitis in head and neck cancer patients treated with primary radiotherapy and cetuximab. Strahlenther Onkol 2011;187:373\u20137.","journal-title":"Strahlenther Onkol"},{"key":"1111_CR21","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.ijrobp.2005.10.039","volume":"64","author":"R. Semrau","year":"2006","unstructured":"Semrau R, Mueller RP, Stuetzer H et al. Efficacy of intensified hyperfractionated and accelerated radiotherapy and concurrent chemotherapy with carboplatin and 5-fluorouracil: updated results of a randomized multicentric trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2006;64:1308\u201316.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1111_CR22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00066-010-2178-2","volume":"187","author":"S. Semrau","year":"2011","unstructured":"Semrau S, Waldfahrer F, Lell M et al. Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradiotherapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. Early results. Strahlenther Onkol 2011;187:15\u201322.","journal-title":"Strahlenther Onkol"},{"key":"1111_CR23","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s00066-009-1989-5","volume":"185","author":"D. Steinmann","year":"2009","unstructured":"Steinmann D, Cerny B, Karstens J et al. Chemoradiotherapy with weekly cisplatin 40 mg\/m2 in 103 head-and-neck cancer patients. Strahlenther Onkol 2009;185:682\u20138.","journal-title":"Strahlenther Onkol"},{"key":"1111_CR24","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1200\/JCO.2001.19.3.800","volume":"19","author":"J.B. Sunwoo","year":"2001","unstructured":"Sunwoo JB, Herscher LL, Kroog GS et al. Concurrent paclitaxel and radiation in the treatment of locally advanced head and neck cancer. J Clin Oncol 2001;19:800\u201311.","journal-title":"J Clin Oncol"},{"key":"1111_CR25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0360-3016(00)00408-9","volume":"47","author":"M. Suntharalingam","year":"2000","unstructured":"Suntharalingam M, Haas ML, Conley BA et al. The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys 2000;47:49\u201356.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1111_CR26","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00066-009-1992-x","volume":"185","author":"S. Tribius","year":"2009","unstructured":"Tribius S, Kronemann S, Kilic Y et al. Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck. Strahlenther Onkol 2009;185:675\u201381.","journal-title":"Strahlenther Onkol"},{"key":"1111_CR27","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s00066-010-2136-z","volume":"186","author":"H.A. Wolff","year":"2010","unstructured":"Wolff HA, Bosch J, Jung K et al. High-grade acute organ toxicity as positive prognostic factor in primary radio(chemo)therapy for locally advanced, inoperable head and neck cancer. Strahlenther Onkol 2010;186:262\u20138.","journal-title":"Strahlenther Onkol"},{"key":"1111_CR28","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/cncr.25721","volume":"117","author":"S.J. Wong","year":"2011","unstructured":"Wong SJ, Harari PM, Garden AS et al. Longitudinal oncology registry of head and neck carcinoma (LORHAN): analysis of chemoradiation treatment approaches in the United States. Cancer 2011;117:1679\u201386.","journal-title":"Cancer"},{"key":"1111_CR29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00066-010-2149-7","volume":"187","author":"F. Zwicker","year":"2011","unstructured":"Zwicker F, Roeder F, Thieke C et al. IMRT reirradiation with concurrent cetuximab immunotherapy in recurrent head and neck cancer. Strahlenther Onkol 2011;187:32\u20138..","journal-title":"Strahlenther Onkol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-011-1111-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-011-1111-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-011-1111-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,16]],"date-time":"2019-06-16T05:14:35Z","timestamp":1560662075000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-011-1111-7"}},"subtitle":["A phase II study"],"short-title":[],"issued":{"date-parts":[[2011,9,23]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["1111"],"URL":"https:\/\/doi.org\/10.1007\/s00066-011-1111-7","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,23]]}}}